{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:05:05Z","timestamp":1778918705911,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T00:00:00Z","timestamp":1366070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00210-013-0867-y","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T01:42:19Z","timestamp":1365990139000},"page":"685-695","source":"Crossref","is-referenced-by-count":24,"title":["Augmentation therapy with alpha-lipoic acid and desvenlafaxine: A future target for treatment of depression?"],"prefix":"10.1007","volume":"386","author":[{"given":"M\u00e1rcia Calheiros Chaves","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caren N\u00e1dia Soares","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Rafael Leite","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiara Coelho","family":"Ximenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Victor Pontes","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9ssica Calheiros","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzyana Lima","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca Cl\u00e9a Floren\u00e7o","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Silveira","family":"Mac\u00eado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silv\u00e2nia Maria Mendes","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,16]]},"reference":[{"key":"867_CR1","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.neuropharm.2008.08.026","volume":"55","author":"Y Ago","year":"2008","unstructured":"Ago Y, Arikawa S, Yata M, Yano K, Abe M, Takuma K, Matsuda T (2008) Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. Neuropharmacol 55:1355\u20131363","journal-title":"Neuropharmacol"},{"key":"867_CR2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2012.09.008","volume":"65","author":"Y Ago","year":"2013","unstructured":"Ago Y, Yano K, Araki R, Hiramatsu N, Kita Y, Kawasaki T, Onoe H, Chaki S, Nakazato A, Hashimoto H, Baba A, Takuma K, Matsuda T (2013) Metabotropic glutamate 2\/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice. Neuropharmacol 65:29\u201338","journal-title":"Neuropharmacol"},{"key":"867_CR3","first-page":"S9","volume":"106","author":"Y Aina","year":"2006","unstructured":"Aina Y, Susman JL (2006) Understanding comorbidity with depression and anxiety disorders. J Am Osteopath Assoc 106:S9\u2013S14","journal-title":"J Am Osteopath Assoc"},{"key":"867_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2006.04.057","volume":"7","author":"PD Alfinito","year":"2006","unstructured":"Alfinito PD, Huselton C, Chen X, Deecher DC (2006) Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague-Dawley rats. Brain Res 7:71\u201378","journal-title":"Brain Res"},{"key":"867_CR5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.yhbeh.2006.06.031","volume":"50","author":"M Altemus","year":"2006","unstructured":"Altemus M (2006) Sex differences in depression and anxiety disorders: potential biological determinants. Horm Behav 50:534\u2013538","journal-title":"Horm Behav"},{"key":"867_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0003-3472(73)80065-X","volume":"21","author":"J Archer","year":"1973","unstructured":"Archer J (1973) Tests for emotionality in rats and mice: a review. Anim Behav 21:205\u2013235","journal-title":"Anim Behav"},{"key":"867_CR7","first-page":"13","volume":"2012","author":"GA Behr","year":"2012","unstructured":"Behr GA, Moreira JCF, Frey BN (2012) Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid Med Cell Longev 2012:13","journal-title":"Oxid Med Cell Longev"},{"key":"867_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351\u2013354","journal-title":"Biol Psychiatry"},{"key":"867_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S1461145711001842","volume":"16","author":"E Berrocoso","year":"2013","unstructured":"Berrocoso E, Ikeda K, Sora I, Uhl GR, Sanchez-Blazquez P, Mico JA (2013) Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. Int J Neuropsychopharmacol 16:151\u2013162","journal-title":"Int J Neuropsychopharmacol"},{"key":"867_CR10","first-page":"570","volume":"57","author":"A Bilska","year":"2005","unstructured":"Bilska A, Wlodek L (2005) Lipoic acid\u2014the drug of the future? Pharmacol Rep 57:570\u2013577","journal-title":"Pharmacol Rep"},{"key":"867_CR11","first-page":"32130","volume":"22","author":"A Carballedo","year":"2013","unstructured":"Carballedo A, Morris D, Zill P, Fahey C, Reinhold E, Meisenzahl E, Bondy B, Gill M, Moller HJ, Frodl T (2013) Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. Am J Med Genet B Neuropsychiatr Genet 22:32130","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"867_CR12","first-page":"3","volume":"19","author":"N Carrier","year":"2013","unstructured":"Carrier N, Kabbaj M (2013) Sex differences in the antidepressant-like effects of ketamine. Neuropharmacol 19:3\u20138","journal-title":"Neuropharmacol"},{"key":"867_CR13","first-page":"665","volume":"11","author":"CP Chung","year":"2012","unstructured":"Chung CP, Schmidt D, Stein CM, Morrow JD, Salomon RM (2012) Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res 11:665\u2013668","journal-title":"Psychiatry Res"},{"key":"867_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S1092852900020204","volume":"14","author":"AH Clayton","year":"2009","unstructured":"Clayton AH, Kornstein SG, Rosas G, Guico-Pabia C, Tourian KA (2009) An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder. CNS Spectr 14:183\u2013195","journal-title":"CNS Spectr"},{"key":"867_CR15","first-page":"12085","volume":"27","author":"RB Dalby","year":"2013","unstructured":"Dalby RB, Elfving B, Poulsen PH, Foldager L, Frandsen J, Videbech P, Rosenberg R (2013) Plasma brain-derived neurotrophic factor and prefrontal white matter integrity in late-onset depression and normal aging. Acta Psychiatr Scand 27:12085","journal-title":"Acta Psychiatr Scand"},{"key":"867_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-002-1335-4","volume":"166","author":"DJ David","year":"2003","unstructured":"David DJ, Renard CE, Jolliet P, Hascoet M, Bourin M (2003) Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology 166:373\u2013382","journal-title":"Psychopharmacology"},{"key":"867_CR17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","volume":"62","author":"DJ David","year":"2009","unstructured":"David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, Hen R (2009) Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety\/depression. Neuron 62:479\u2013493","journal-title":"Neuron"},{"key":"867_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00207454.2010.535934","volume":"121","author":"DP Araujo De","year":"2011","unstructured":"De Araujo DP, Lobato Rde F, Cavalcanti JR, Sampaio LR, Araujo PV, Silva MC, Neves KR, Fonteles MM, Sousa FC, Vasconcelos SM (2011) The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson\u2019s disease: a review. Int J Neurosci 121:51\u201357","journal-title":"Int J Neurosci"},{"key":"867_CR19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4172\/jbb.1000076","volume":"3","author":"W DeMaio","year":"2011","unstructured":"DeMaio W, Kane C, Nichols A, Jordan R (2011) Metabolism studies of desvenlafaxine. J Bioequiv Availab 3:151\u2013160","journal-title":"J Bioequiv Availab"},{"key":"867_CR20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2009.08.051","volume":"464","author":"PM Ferreira","year":"2009","unstructured":"Ferreira PM, Militao GC, Freitas RM (2009) Lipoic acid effects on lipid peroxidation level, superoxide dismutase activity, and monoamines concentration in rat hippocampus. Neurosci Lett 464:131\u2013134","journal-title":"Neurosci Lett"},{"key":"867_CR21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopsych.2009.02.027","volume":"66","author":"AL Garcia-Garcia","year":"2009","unstructured":"Garcia-Garcia AL, Elizalde N, Matrov D, Harro J, Wojcik SM, Venzala E, Ramirez MJ, Del Rio J, Tordera RM (2009) Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol Psychiatry 66:275\u2013282","journal-title":"Biol Psychiatry"},{"key":"867_CR22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S0033291712001110","volume":"43","author":"MI Geerlings","year":"2013","unstructured":"Geerlings MI, Sigurdsson S, Eiriksdottir G, Garcia ME, Harris TB, Sigurdsson T, Gudnason V, Launer LJ (2013) Associations of current and remitted major depressive disorder with brain atrophy: the AGES-Reykjavik Study. Psychol Med 43:317\u2013328","journal-title":"Psychol Med"},{"key":"867_CR23","doi-asserted-by":"crossref","unstructured":"Gourley SL, Taylor JR (2009) Recapitulation and reversal of a persistent depression-like syndrome in rodents. Curr Protoc Neurosci Chapter 9:Unit 9.32. doi: 10.1002\/0471142301.ns0932s49","DOI":"10.1002\/0471142301.ns0932s49"},{"key":"867_CR24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4088\/JCP.v64n1211","volume":"64","author":"PE Greenberg","year":"2003","unstructured":"Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK (2003) The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 64:1465\u20131475","journal-title":"J Clin Psychiatry"},{"key":"867_CR25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2004.05.013","volume":"156","author":"A Gregus","year":"2005","unstructured":"Gregus A, Wintink AJ, Davis AC, Kalynchuk LE (2005) Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res 156:105\u2013114","journal-title":"Behav Brain Res"},{"key":"867_CR26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1096\/fasebj.13.2.411","volume":"13","author":"TM Hagen","year":"1999","unstructured":"Hagen TM, Ingersoll RT, Lykkesfeldt J, Liu J, Wehr CM, Vinarsky V, Bartholomew JC, Ames AB (1999) (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J 13:411\u2013418","journal-title":"FASEB J"},{"key":"867_CR27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0278-5846(03)00149-0","volume":"27","author":"MN Hill","year":"2003","unstructured":"Hill MN, Brotto LA, Lee TT, Gorzalka BB (2003) Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats. Prog Neuropsychopharmacol Biol Psychiatry 27:905\u2013911","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"867_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2011.02.030","volume":"493","author":"Z Huang","year":"2011","unstructured":"Huang Z, Zhong XM, Li ZY, Feng CR, Pan AJ, Mao QQ (2011) Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats. Neurosci Lett 493:145\u2013148","journal-title":"Neurosci Lett"},{"key":"867_CR29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2010.08.078","volume":"4","author":"M Iijima","year":"2010","unstructured":"Iijima M, Ito A, Kurosu S, Chaki S (2010) Pharmacological characterization of repeated corticosterone injection-induced depression model in rats. Brain Res 4:75\u201380","journal-title":"Brain Res"},{"key":"867_CR30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2005.11.019","volume":"168","author":"SA Johnson","year":"2006","unstructured":"Johnson SA, Fournier NM, Kalynchuk LE (2006) Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav Brain Res 168:280\u2013288","journal-title":"Behav Brain Res"},{"key":"867_CR31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1037\/0735-7044.118.6.1365","volume":"118","author":"LE Kalynchuk","year":"2004","unstructured":"Kalynchuk LE, Gregus A, Boudreau D, Perrot-Sinal TS (2004) Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats. Behav Neurosci 118:1365\u20131377","journal-title":"Behav Neurosci"},{"key":"867_CR32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijdevneu.2012.12.006","volume":"31","author":"J Kleinkauf-Rocha","year":"2012","unstructured":"Kleinkauf-Rocha J, Bobermin LD, Machado PD, Goncalves CA, Gottfried C, Quincozes-Santos A (2012) Lipoic acid increases glutamate uptake, glutamine synthetase activity, and glutathione content in C6 astrocyte cell line. Int J Dev Neurosci 31:165\u2013170","journal-title":"Int J Dev Neurosci"},{"key":"867_CR33","first-page":"18","volume":"16","author":"SG Kornstein","year":"2001","unstructured":"Kornstein SG, Schneider RK (2001) Clinical features of treatment-resistant depression. J Clin Psychiatry 16:18\u201325","journal-title":"J Clin Psychiatry"},{"key":"867_CR34","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894\u2013902","journal-title":"Nature"},{"key":"867_CR35","first-page":"4","volume":"9","author":"M Kubera","year":"2013","unstructured":"Kubera M, Curzytek K, Duda W, Leskiewicz M, Basta-Kaim A, Budziszewska B, Roman A, Zajicova A, Holan V, Lason W, Maes M (2013) A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4\u00a0months. Brain Behav Immun 9:4","journal-title":"Brain Behav Immun"},{"key":"867_CR36","first-page":"67","volume":"4","author":"DZ Lieberman","year":"2010","unstructured":"Lieberman DZ, Massey SH (2010) Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy. Core Evid 4:67\u201382","journal-title":"Core Evid"},{"key":"867_CR37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/YIC.0b013e32830263de","volume":"23","author":"DZ Lieberman","year":"2008","unstructured":"Lieberman DZ, Montgomery SA, Tourian KA, Brisard C, Rosas G, Padmanabhan K, Germain JM, Pitrosky B (2008) A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder. Int Clin Psychopharmacol 23:188\u2013197","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"867_CR38","first-page":"e1","volume":"12","author":"MR Liebowitz","year":"2010","unstructured":"Liebowitz MR, Tourian KA (2010) Efficacy, safety, and tolerability of desvenlafaxine 50\u00a0mg\/d for the treatment of major depressive disorder: a systematic review of clinical trials. Prim Care Companion J Clin Psychiatry 12(3):e1\u2013e10","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"867_CR39","first-page":"180","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180\u2013185","journal-title":"Psychopharmacology"},{"key":"867_CR40","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.psyneuen.2011.12.003","volume":"37","author":"W Liu","year":"2012","unstructured":"Liu W, Zhou C (2012) Corticosterone reduces brain mitochondrial function and expression of mitofusin, BDNF in depression-like rodents regardless of exercise preconditioning. Psychoneuroendocrinology 37:1057\u20131070","journal-title":"Psychoneuroendocrinology"},{"key":"867_CR41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1399-5618.2012.01046.x","volume":"14","author":"DS Macedo","year":"2012","unstructured":"Macedo DS, Medeiros CD, Cordeiro RC, Sousa FC, Santos JV, Morais TA, Hyphantis TN, McIntyre RS, Quevedo J, Carvalho AF (2012) Effects of alpha-lipoic acid in an animal model of mania induced by d-amphetamine. Bipolar Disord 14:707\u2013718","journal-title":"Bipolar Disord"},{"key":"867_CR42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63:349\u2013352","journal-title":"Biol Psychiatry"},{"key":"867_CR43","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35:676\u2013692","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"867_CR44","first-page":"66","volume":"20","author":"RB Mansur","year":"2012","unstructured":"Mansur RB, Cha DS, Asevedo E, McIntyre RS, Brietzke E (2012) Selfish brain and neuroprogression in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 20:66\u201371","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"867_CR45","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442","journal-title":"PLoS Med"},{"key":"867_CR46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11599770-000000000-00000","volume":"26","author":"SJ Mathew","year":"2012","unstructured":"Mathew SJ, Shah A, Lapidus K, Clark C, Jarun N, Ostermeyer B, Murrough JW (2012) Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs 26:189\u2013204","journal-title":"CNS Drugs"},{"key":"867_CR47","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1176\/appi.ajp.163.9.1531","volume":"163","author":"PJ McGrath","year":"2006","unstructured":"McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ (2006) Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry 163:1531\u20131541","journal-title":"Am J Psychiatry"},{"key":"867_CR48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2008.01.014","volume":"583","author":"F Murray","year":"2008","unstructured":"Murray F, Smith DW, Hutson PH (2008) Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol 583:115\u2013127","journal-title":"Eur J Pharmacol"},{"key":"867_CR49","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1371\/journal.pone.0008566","volume":"5","author":"L Musazzi","year":"2010","unstructured":"Musazzi L, Milanese M, Farisello P, Zappettini S, Tardito D, Barbiero VS, Bonifacino T, Mallei A, Baldelli P, Racagni G, Raiteri M, Benfenati F, Bonanno G, Popoli M (2010) Acute stress increases depolarization-evoked glutamate release in the rat prefrontal\/frontal cortex: the dampening action of antidepressants. PLoS One 5:8566","journal-title":"PLoS One"},{"key":"867_CR50","first-page":"937","volume":"4","author":"JC Nelson","year":"2008","unstructured":"Nelson JC, Pikalov A, Berman RM (2008) Augmentation treatment in major depressive disorder: focus on aripiprazole. Neuropsychiatr Dis Treat 4:937\u2013948","journal-title":"Neuropsychiatr Dis Treat"},{"key":"867_CR51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1371\/journal.pone.0020719","volume":"6","author":"E Painsipp","year":"2011","unstructured":"Painsipp E, Kofer MJ, Sinner F, Holzer P (2011) Prolonged depression-like behavior caused by immune challenge: influence of mouse strain and social environment. PLoS One 6:6","journal-title":"PLoS One"},{"key":"867_CR52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/nedt.2007.3.1.169","volume":"3","author":"GI Papakostas","year":"2007","unstructured":"Papakostas GI, Hallett LA, Smith J, Tossani E, Mascarini A, Burns AM, Birnbaum RJ, Fava M, Alpert JE (2007) A survey of five antidepressant properties influencing clinician\u2019s treatment choices in MDD. Neuropsychiatr Dis Treat 3:169\u2013172","journal-title":"Neuropsychiatr Dis Treat"},{"key":"867_CR53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ncb2141","volume":"13","author":"M Popoli","year":"2011","unstructured":"Popoli M, Yan Z, McEwen BS, Sanacora G (2011) The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 13:22\u201337","journal-title":"Nat Rev Neurosci"},{"key":"867_CR54","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"867_CR55","first-page":"24","volume":"24","author":"D Rai","year":"2013","unstructured":"Rai D, Zitko P, Jones K, Lynch J, Araya R (2013) Country- and individual-level socioeconomic determinants of depression: multilevel cross-national comparison. Br J Psychiatry 24:24","journal-title":"Br J Psychiatry"},{"key":"867_CR56","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659\u2013661","journal-title":"FASEB J"},{"key":"867_CR57","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1054\/mehy.2000.1103","volume":"55","author":"MR Salazar","year":"2000","unstructured":"Salazar MR (2000) Alpha lipoic acid: a novel treatment for depression. Med Hypotheses 55:510\u2013512","journal-title":"Med Hypotheses"},{"key":"867_CR58","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1073\/pnas.231475998","volume":"98","author":"RM Sapolsky","year":"2001","unstructured":"Sapolsky RM (2001) Depression, antidepressants, and the shrinking hippocampus. Proc Natl Acad Sci U S A 98:12320\u201312322","journal-title":"Proc Natl Acad Sci U S A"},{"key":"867_CR59","unstructured":"Silva MC, Sampaio LR, Araujo DP, Araujo PV, Monte AS, Rodrigues FT, Woods DJ, Sousa FCF, Fonteles MM, Vasconcelos SM (in press) Central effects of lipoic acid associated with paroxetine in mice. Am J Ther"},{"key":"867_CR60","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1517\/13543784.17.6.827","volume":"17","author":"JK Soczynska","year":"2008","unstructured":"Soczynska JK, Kennedy SH, Chow CS, Woldeyohannes HO, Konarski JZ, McIntyre RS (2008) Acetyl-l-carnitine and alpha-lipoic acid: possible neurotherapeutic agents for mood disorders? Expert Opin Investig Drugs 17:827\u2013843","journal-title":"Expert Opin Investig Drugs"},{"key":"867_CR61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"867_CR62","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.pnpbp.2007.11.012","volume":"32","author":"A Szuster-Ciesielska","year":"2008","unstructured":"Szuster-Ciesielska A, Slotwinska M, Stachura A, Marmurowska-Michalowska H, Dubas-Slemp H, Bojarska-Junak A, Kandefer-Szerszen M (2008) Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 32:686\u2013694","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"867_CR63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1383\/psyt.2006.5.5.166","volume":"5","author":"S Watson","year":"2006","unstructured":"Watson S, Mackin P (2006) HPA axis function in mood disorders. Psychiatry 5:166\u2013170","journal-title":"Psychiatry"},{"key":"867_CR64","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jep.2012.10.013","volume":"144","author":"L Ye","year":"2012","unstructured":"Ye L, Hu Z, Du G, Zhang J, Dong Q, Fu F, Tian J (2012) Antidepressant-like effects of the extract from Cimicifuga foetida L. J Ethnopharmacol 144:683\u2013691","journal-title":"J Ethnopharmacol"},{"key":"867_CR65","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864","journal-title":"Arch Gen Psychiatry"},{"key":"867_CR66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2010.09.095","volume":"17","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Gu F, Chen J, Dong W (2010) Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Res 17:141\u2013148","journal-title":"Brain Res"},{"key":"867_CR67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2007.12.005","volume":"581","author":"Y Zhao","year":"2008","unstructured":"Zhao Y, Ma R, Shen J, Su H, Xing D, Du L (2008) A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 581:113\u2013120","journal-title":"Eur J Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-013-0867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-013-0867-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-013-0867-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T14:31:25Z","timestamp":1562941885000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-013-0867-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,16]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["867"],"URL":"https:\/\/doi.org\/10.1007\/s00210-013-0867-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,16]]}}}